|
|
||||||||
From the Center for Research in the Neurosciences, Montreal General Hospital, and Department of Neurology and Neurosurgery (Drs. Davenport and Rouleau), McGill University, Montreal, Quebec, Canada; Epilepsy Program (Dr. Siegel), Department of Neurology, University Hospital Zürich, Switzerland; Department of Neurology (Dr. Dichgans), University of Tübingen, Germany; Department of Pediatrics (Drs. Drigo and Mammi), University of Padua, Italy; Clinica Neurologica (Dr. Pereda), Ospedalo Universitario, Montevideo, Uruguay; and the Institute of Neurology and Neurogenetics (Dr. Wood), National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Address correspondence and reprint requests to Dr. Guy Rouleau, Center for Research in Neurosciences, Montreal General Hospital, and Department of Neurology and Neurosurgery, McGill University, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4 Canada; e-mail: mi32{at}musica.mcgill.ca
Cerebral cavernous malformations (CCM) are vascular anomalies, sometimes inherited as an autosomal dominant trait, which can cause strokes and seizures. Recently, mutations of the CCM1 gene (chromosome 7q) have been found in a subset of families. The authors found 10 new mutations by screening 29 families and five seemingly sporadic cases of CCM. The mutations predicted truncation of the Krit1 mRNA encoded by CCM1, supporting the contention that CCM result from loss of Krit1 protein function and the possibility that this protein acts as a tumor suppressor.
This article has been cited by other articles:
![]() |
A. L. Akers, E. Johnson, G. K. Steinberg, J. M. Zabramski, and D. A. Marchuk Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 919 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Battistini, R. Rocchi, A. Cerase, A. Citterio, L. Tassi, G. Lando, M. C. Patrosso, R. Galli, P. Brunori, D. L. Sgro, et al. Clinical, Magnetic Resonance Imaging, and Genetic Study of 5 Italian Families With Cerebral Cavernous Malformation Arch Neurol, June 1, 2007; 64(6): 843 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reich, J. Winkler, A. Straube, H.J. Steiger, and A. Peraud Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas Neurology, April 8, 2003; 60(7): 1135 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski Vascular morphogenesis: tales of two syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R97 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gunel, M. S. H. Laurans, D. Shin, M. L. DiLuna, J. Voorhees, K. Choate, C. Nelson-Williams, and R. P. Lifton KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein PNAS, August 6, 2002; 99(16): 10677 - 10682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Verlaan, W. J. Davenport, H. Stefan, U. Sure, A. M. Siegel, and G. A. Rouleau Cerebral cavernous malformations: Mutations in Krit1 Neurology, March 26, 2002; 58(6): 853 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zawistowski, I. G. Serebriiskii, M. F. Lee, E. A. Golemis, and D. A. Marchuk KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis Hum. Mol. Genet., February 1, 2002; 11(4): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. E. Clatterbuck, D. Rigamonti, D. D. Chang, and H. C. Dietz Interaction between krit1 and icap1{alpha} infers perturbation of integrin {beta}1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation Hum. Mol. Genet., December 1, 2001; 10(25): 2953 - 2960. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |